4/A
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000027
Chief Medical Officer acquired 14,200 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KREHER NERISSA Chief Medical Officer | 2023-03-01 | Grant or award | +14,200 | 27,130 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KREHER NERISSA Chief Medical Officer | 2023-03-01 | Grant or award · Stock Option (Right to Buy) | +21,500 | 21,500 | D: show line 2 in the form |
Loading xslF345X04/wf-form4a_168194087335878.xml…